Altogether, these data provide functional confirmation of the importance and critical role of DOT1L recruitment in MLL-AF9-driven leukemogenesis, validating these protein-protein interactions as a potential therapeutic target in MLL-rearranged leukemia. This evidence concerns the gene DOT1L and leukemia.